| Product Code: ETC9961149 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States saw significant bone morphogenetic proteins import shipments from Austria, Metropolitan France, Italy, Germany, and Brazil, with a notably low concentration level indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was -31.87%, reflecting a decline in imports over the period. Additionally, the growth rate from 2023 to 2024 was -39.06%, underscoring a further decrease in import activity. This data suggests a challenging market environment for bone morphogenetic proteins imports into the US, potentially influenced by various factors impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Bone Morphogenetic Proteins Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Bone Morphogenetic Proteins Market - Industry Life Cycle |
3.4 United States (US) Bone Morphogenetic Proteins Market - Porter's Five Forces |
3.5 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume Share, By Applications, 2021 & 2031F |
4 United States (US) Bone Morphogenetic Proteins Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of orthopedic disorders and bone-related diseases in the US |
4.2.2 Growing geriatric population leading to higher demand for bone morphogenetic proteins |
4.2.3 Technological advancements in healthcare and orthopedic treatments |
4.3 Market Restraints |
4.3.1 High cost associated with bone morphogenetic proteins limiting adoption rates |
4.3.2 Stringent regulatory approval processes for bone morphogenetic proteins |
4.3.3 Potential side effects and complications associated with the use of these proteins |
5 United States (US) Bone Morphogenetic Proteins Market Trends |
6 United States (US) Bone Morphogenetic Proteins Market, By Types |
6.1 United States (US) Bone Morphogenetic Proteins Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, By rhBMP-2, 2021- 2031F |
6.1.4 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, By rhbmp-7, 2021- 2031F |
6.2 United States (US) Bone Morphogenetic Proteins Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, By Spinal Fusion, 2021- 2031F |
6.2.3 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, By Trauma, 2021- 2031F |
6.2.4 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, By Reconstructive, 2021- 2031F |
6.2.5 United States (US) Bone Morphogenetic Proteins Market Revenues & Volume, By Oral, 2021- 2031F |
7 United States (US) Bone Morphogenetic Proteins Market Import-Export Trade Statistics |
7.1 United States (US) Bone Morphogenetic Proteins Market Export to Major Countries |
7.2 United States (US) Bone Morphogenetic Proteins Market Imports from Major Countries |
8 United States (US) Bone Morphogenetic Proteins Market Key Performance Indicators |
8.1 Number of FDA approvals for new bone morphogenetic proteins products |
8.2 Adoption rate of bone morphogenetic proteins in orthopedic surgeries |
8.3 Research and development investment in bone morphogenetic proteins technologies and products |
9 United States (US) Bone Morphogenetic Proteins Market - Opportunity Assessment |
9.1 United States (US) Bone Morphogenetic Proteins Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 United States (US) Bone Morphogenetic Proteins Market Opportunity Assessment, By Applications, 2021 & 2031F |
10 United States (US) Bone Morphogenetic Proteins Market - Competitive Landscape |
10.1 United States (US) Bone Morphogenetic Proteins Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Bone Morphogenetic Proteins Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here